Farhad Ravandi, MD- The Impact of Minimal Residual Disease Acute Myelogenous Leukemia 1 Min Read11 Farhad Ravandi, MD is Janiece and Stephen A. Lasher Professor of Medicine and Chief of Section of Developmental Therapeutics in…
Farhad Ravandi, MD – Assesing Residual Leukemia/Menin inhibitors Acute Myelogenous Leukemia 1 Min Read32 Farhad Ravandi-Kashani, M.D. Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston,…
